Capital Advisors Ltd’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Sell
80
-404
-83% -$1.12K ﹤0.01% 1477
2026
Q2
$1K Buy
+484
New +$1.43K ﹤0.01% 1174

Other funds holding AVXL

Capital Advisors Ltd's AVXL Position: Q3 2026 in Review

Capital Advisors Ltd reduced its Anavex Life Sciences (AVXL) stake by 83% in Q3 2026, selling an estimated $1.12K and leaving 80 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Capital Advisors Ltd first reported a position in AVXL in Q2 2026 and has held it in 2 quarters since. The position peaked at $1K in Q2 2026. 167 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Capital Advisors Ltd held 80 shares of Anavex Life Sciences worth $0 as of Q3 2026.
  • Capital Advisors Ltd sold 404 Anavex Life Sciences shares in Q3 2026, an estimated $1.12K.
  • Anavex Life Sciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q3 2026, its #1477 holding.
  • Capital Advisors Ltd first reported a position in Anavex Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Capital Advisors Ltd's Anavex Life Sciences position peaked at $1K in Q2 2026.
  • 167 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Capital Advisors Ltd's 13F filing for Q3 2026, filed 27 Oct 2026.